Wednesday 21 September
Please find below the programme schedule for Wednesday 21 September 2022.
08:00
Conference hall B | General Assembly
09:30
Conference hall B | Presidential oration
Speaker: Dr. John Perfect, USA | Chair: Arunaloke Chakrabarti, India
10:30
Break
Conference hall C - Exhibition
Parallel session I
Parallel session I will take place from 11:00 AM - 12:30 PM and consists of five symposia.
Conference hall B | S1.1 Controversies in the clinical management of invasive candidiasis in critically ill patients
Chairs: Subhash Todi, India and Arnaldo Lopes Colombo, Brazil
11:00
S1.1a Gaps in the guidelines for the clinical management of candidemia
Arnaldo Lopes Colombo, Brazil
11:20
S1.1b Should we continue to use conventional doses of candins for all ICU patients?
Subhash Todi, India
11:40
S1.1c Intra-abdominal candidiasis: best clinical management and strategies to monitor response to therapy
Prakash Shastri, India
12:00
S1.1d* Risk Factors Associated with Oropharyngeal Candidiasis in COVID-19 Patients: A Case Control Study
Mohammadreza Salehi, Iran
12:15
Q&A with all speakers
Conference hall A | S1.2 S Animal Mycoses
Chairs: Vanessa Barrs, Hong Kong and Andrea Peano, Italy
11:00
S1.2a 'Veterinary relevant and zoonotic fungal groups'
Amir Seyedmousavi, USA
11:20
S1.2b Penicilliosis: an emerging concern in dogs?
Jacques Guillot, France
11:40
S1.2c Diagnosis of fungal infections in animals: combining the old and the new to maximize results
Andrea Peano, Italy
12:00
S1.2d* TBD
12:15
Q&A with all speakers
Suite No. 292 (Ruby) | S1.3 Malassezia: genetics, genomics, and biology
Chairs: Kaustuv Sanyal, India / Shivaprakash Rudramurthy, India
11:00
S1.3a Molecular taxonomy of Malassezia
Prasanna Honnavar, Antigua & Barbuda
11:20
S1.3b Chromosomal stability and speciation in the Malassezia Clade
Kaustuv Sanyal, India
11:40
S1.3c Diversity and hybridization in Malassezia furfur
Bart Theelen, Netherlands
12:00
S1.3d* The human pathobiont Malassezia furfur secreted protease MfSAP1 regulates cell dispersal and exacerbates skin inflammation
Salomé LeibundGut-Landmann, Switzerland
12:15
Q&A with all speakers
Suite No. 293 (Sapphire) S1.4 Fungal infections in Asia, bringing it out of the dark
Chairs: Yee-Chun Chen, Taiwan and Ariya Chindamporn, Thailand
11:00
S1.4a Paradigm shift in the epidemiology of invasive fungal infections during COVID-19 pandemics
Atul Patel, India
11:20
S1.4b Challenges in diagnosing & management of invasive fungal infections during pandemic
Methee Chayakulkeeree, Thailand
11:40
S1.4c Antifungal stewardship & infection control
Pratibha Kale, India
12:00
S1.4d* Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing cryptococcosis
Alexandre Alanio, France
12:15
Q&A with all speakers
Suite No. 294 (Emerald) | S1.5 Mycotic Keratitis
Chairs: Savitri Sharma, India and Niranjan Nayak, India
11:00
S1.5a Epidemiology of myotic keratitis in developing countries
Phillip Thomas, India
11:20
S1.5b Epidemiology of mycotic keratitis in West Africa
Savitri Sharma, India
11:40
S1.5c Proteomics approach in the understanding of fungal keratitis
Lalitha Prajna, India
12:00
S1.5d* Spectrum of Aetiological agents of Mycotic keratitis: A 11 year review
Phillip Thomas, India
12:15
Q&A with all speakers
12:30
Lunch and Poster session 1
Conference hall C - Exhibition
Conference hall B | Sponsored symposium 1: Pragmatic approach in management of invasive mold infection (IMI)
This symposium is sponsored by Gilead
12:30
Welcome
Dr. Arunaloke Chakrabarti
12:35
Current trends in epidemiology and resistance
Dr. Arunaloke Chakrabarti
12:45
What are the challenges and approaches in IMI diagnoses?
Dr. Martin Honigl
13:15
Why empirical therapy in management of IMI in hematological patients?
Dr. Johan Maertens
13:45
Q&A
With all speakers
13:55
Close
Dr. Arunaloke Chakrabarti
14:00
Conference hall B | Keynote (P1): Recent Developments of the ECMM-ISHAM-ASM Global Guideline Program
Oliver Cornely, Germany
Parallel session 2
Parallel session 2 will take place from 03:00 - 04:30 PM and consists of five symposia.
Conference hall B | S2.1 Update on Mucormycosis
Chairs: Atul Patel, India and Arunaloke Chakrabarti, India
15:00
S2.1a Mucormycosis in Developing/Asian country
Atul Patel, India
15:20
S2.1b Update in pathogenesis and diagnosis of mucormycosis
Ashraf Ibrahim, USA
15:40
S2.1c Global guideline in management
Oliver Cornely, Germany
16:00
S2.1d* Incidence of mixed fungal infections in Post-Covid-19 outbreak of Mucormycosis
Subhashree Mohapatra, India
16:15
Q&A with all speakers
Conference hall A | S2.2 Histoplasmosis & Talaromycosis
Chairs: David Denning, UK and Malini Capoor, India
15:00
S2.2a African histoplasmosis
Rita Oladele, Nigeria
15:20
S2.2b Challenges in Latin America
Beatriz Gomez, Colombia
15:40
S2.2c Talaromycosis in HIV-negative Patients: Challenges and Countermeasures
Methee Chayakulkeeree, Thailand
16:00
S2.2d* Evaluation of new tools for the diagnosis of histoplasmosis
Aude Sturny Leclere, France
16:15
Q&A with all speakers
Suite No. 292 (Ruby) | S2.3 Novel Diagnostic tools for Invasive Mold infection
Chairs: Cornelia Lass Flörl, Austria and Martin Hoenigl, Austria
15:00
S2.3a Lateral Flow Device Tests for Diagnosis of Invasive Aspergillosis: What is their role in 2021?
Katrien Lagrou, Belgium
15:20
S2.3b How can Cytokines be used for Diagnosis and Treatment Monitoring of Invasive Mold Infections?
Juergen Prattes, Austria
15:40
S2.3c High Resolution Digital DNA Melting: a breakthrough in diagnosing IMI?
Tyler Goshia, USA
16:00
S2.3d* Mixed biofilm of Aspergillus fumigatus and Stenotrophomonas maltophilia: microscopic visualization of galactosaminogalactan and galactomannan polysaccharides in the extracellular matrix
Françoise Botterel, France
16:15
Q&A with all speakers
Suite No. 293 (Sapphire) | S2.4 Veterinary Mycology Research
Chairs: Jacques Guillot, France and Amir Seyedmousavi, USA
15:00
S2.4a Pythiosis: an emerging disease in Hong Kong
Vanessa Barrs, Hong Kong
15:20
S2.4b Population biology of hedgehog fungus Trichophyton eninacei
Vit Hubka, Czech Republic
15:40
S2.4c Metagenomic analysis of histoplasmosis in dogs
Gregory Jouvion, France
16:00
S2.4d* TBD
16:15
Q&A with all speakers
Suite No. 294 (Emerald) | S2.5 Rare Yeasts
Chair: Peter-Michael Rath, Germany
15:00
S2.5a Magnsiomyces spp.
Axel Hamprecht, Germany
15:20
S2.5b Trichosporon spp.
João Nobrega de Almeida, Brazil
15:40
S2.5c Exophiala spp.
Joerg Steinmann, Germany
16:00
S2.5d* Exploring multidrug resistance, fitness compensation and collateral sensitivity in Candida auris: fight fire with fire?
Hans Carolus, Belgium
16:15
Q&A with all speakers
16:30
Break
Conference hall C - Exhibition
Parallel session 3
Parallel session 3 will take place from 16:45 hrs. until 18:15 hrs. and consists of five symposia.
Conference hall B | S3.1 Neglected implantation mycoses
Chairs: Flavio Queiroz-Telles, Brazil and Alexandro Bonifaz, Mexico
16:45
S3.1a Update in mycetoma control
Ahmed Hassan Fahal, Sudan
17:05
S3.1b Chromoblastomycosis elimination S3.1b Chromoblastomycosis elimination
Daniel Wagner, Brazil
17:25
S3.1c Why sporotrichosis and Paracoccidioidomycosis should be considered neglected tropical disease?
Flavio Queiroz-Telles, Brazil
17:45
S3.1d* High histoplasmosis incidence in kidney transplant recipients in Santa Fe city, Argentina
Guillermo Garcia Effron, Argentina
18:00
Q&A with all speakers
Conference hall A | S3.2 Challenging clinical cases
16:45
For more information about the speakers and panellist member please read more
Speakers:
Rajeev Soman, India
Tanu Singhal, India
Atul Patel, India
Ram Gopalakrishnan, India
16:45-17:30 hrs.
Panellists:
Camilla Rodrigues, India
Subhash Todi, India
John Perfect, USA
Jacques Meis, Netherlands
17.30-18.15
Panellists:
Arunaloke Chakrabarti, India
Ayesha Sunavala, India
Oliver Cornely, Germany
Cornelia Lass-Flörl, Austria
Suite No. 292 (Ruby) | S3.3 Innate immune responses to pathogenic fungi
Chair: Jatin Vyas, USA
16:45
S3.3a Lessons from the clinic: neutrophil heterogeneity in response to Candida
Michael Mansour, USA
17:05
S3.3b role of type i interferons in the host defense against pathogenic fungi
Jatin Vyas, USA
17:25
S3.3c Alveolar Macrophage mediated host resistance against Aspergillus fumigatus
Joshua Obar, USA
17:45
S3.3d* Influenza- versus COVID-19-associated pulmonary aspergillosis: profiling lower respiratory tract epithelial and myeloid innate immunity in patient samples
Simon Feys, Belgium
18:00
Q&A with all speakers
Suite No. 293 (Sapphire) | S3.4 Free oral paper session
Chairs: Shukla Das, India and Nandini Sethuraman, India
16:45
S3.4a* The repurposing approach identifies pitavastatin (calcium) making fluconazole fungicidal by inhibiting ergosterol synthesis
Wanqian Li, China
17:05
S3.4b* Lactoferrin, a natural source of peptides that potentiate the antifungal activity of amphotericin B
Dee Carter, Australia
17:25
S3.4c* A pipeline towards the identification of novel antifungal compounds derived from the microbial dark matter
Giel Vanreppelen, Belgium
17:45
S3.4d* The Role of NLRP3 Inflammasome in Host Defense during Talaromyces marneffei Infection
Sha Lu, China
18:00
S3.4e* Unraveling the role of DOG genes in a novel alternative pathway of glycerol biosynthesis in Candida albicans and its influence on virulence
Chinmayee Awasthy, Belgium
Suite No. 294 (Emerald) | S3.5 Environmental Exposure - Risk for Human Fungal Disease
Chairs: Esther Segal, Israel and Malcolm Richardson, UK
16:45
S3.5a Fungal contamination in sand and water of sea, lakes and river beaches: risk factor for fungal human disease
Esther Segal, Israel
17:05
S3.5b Environment as source of fungal infections: new tools and new concepts
Jean-Pierre Gangneux, France
17:25
S3.5c Animals and soil as source of fungal contamination and exposure acting as risk factor for human fungal infection
Mihai Mares, Romania
17:45
S3.5d* Identification of fungicidal activity of otilonium bromide by the repurposing approach
Cheng Zhen, China
18:00
Q&A with all speakers
18:15
Conference hall B | Key note (P2): Evolution of mating systems and genome organization in budding yeasts
Ken Wolfe, Ireland